Middle East and Africa Radiopharmaceuticals Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Diagnostic Nuclear Medicine and Therapeutic Nuclear Medicine), Application (Oncology, Cardiology, Neurology, and Others), and End User (Hospitals, Imaging Centers, Academic and Research Centers, and Others)
Market Introduction
The MEA radiopharmaceuticals market is analyzed based on Saudi Arabia, UAE, South Africa, and the rest of MEA. Saudi Arabia is one of the largest markets in the region. The prevalence of stroke has been increasing significantly in the Kingdom of Saudi Arabia (KSA), becoming an important cause of illness and deaths in Saudi Arabia. However, research regarding the incidence, prevalence and the socio-demographic properties of stroke is still inadequate as compared with the developed countries. The lack of awareness is expected to be due to lack of appropriate studies being conducted in these specified areas. Stroke is a fast-increasing issue in Saudi Arabia, and it is a leading cause of illness and death. However, in comparison to developed countries, research into the incidence, prevalence, and socio-demographic characteristics of stroke is still lacking due to a lack of adequate studies in these areas. Among Arabs, a large percentage of stroke risk factors are well-known modifiable factors like hypertension and diabetes. The risk of dying from a stroke rises with age, and the risk of dying from a brain hemorrhage is higher. Young stroke accounts for 6–20% of all strokes. Owing to the increasing facilities related to radiopharmaceuticals, increasing prevalence of chronic diseases, the radiopharmaceuticals market in MEA region is anticipated to witness significant growth during the forecast period.
In case of COVID-19, MEA is highly affected especially South Africa. Countries in the Middle East have also widely affected the socio-economic condition by the COVID–19 pandemic. However, the countries have wisely reacted to the COVID–19 pandemic to avoid the spread of infection. Like other regions, lockdown and social distancing were imposed, impairing these trends hindering access to work, regular income, payments, fairs, schools, and healthcare. Therefore, it is expected that the countries have undergone huge losses and are still trying to recover them. The lockdown has widely affected the non-emergency medical services in the region, affecting the medical devices. Countries like Saudi Arabia and UAE are emerging as healthcare destinations in the regions. However, they are dependent on the countries for the resources. The availability of vaccines and other healthcare facilities in the developing countries in the region is expected to provide scope for the market few years. The COVID-19 pandemic has helped the above-mentioned countries enhance their capacity and showcase their abilities for healthcare services. In Saudi Arabia the number of visits for common neurological complaints decreased by 24 percent. In comparison to pre-pandemic, throughout the pandemic period. The most notable example is brain CT scans, which increased by 11.3 percent during the epidemic period. One of the main causes for the decrease in emergency department visits is the fear of catching COVID-19 infection just by visiting hospitals. These factors are likely to have negative impact on the market growth.
Get more information on this report :
Market Overview and Dynamics
The MEA radiopharmaceuticals market is expected to grow from US$ 381.20 million in 2021 to US$ 639.78 million by 2028; it is estimated to grow at a CAGR of 7.7% from 2021 to 2028. The use of nuclear medicine procedures is expanding rapidly, as PET and SPECT continue to improve the accuracy of detection, localization, and characterization of disease. PET and SPECT are among the nuclear medicine radiology modalities employed in clinical settings. As per the Society of Nuclear Medicine, every year, millions of nuclear medicine procedures are performed with radiopharmaceuticals and imaging instruments to diagnose disease and deliver targeted treatments in the countries across the region. These techniques have also been adopted in immunology, infection, gastroenterology, cardiology, oncology, neurology, and psychiatry, among other fields, for diagnosis and other applications. Advanced nuclear medicines and modern imaging equipment are assisting doctors in diagnosing diseases in a better manner and in less time. Continuous development of new radiopharmaceuticals for the PET/CT and SPECT/CT platforms, which are used in novel clinical applications such as neurology and orthopedics, along with the increasing accuracy of different tumor staging methods, are further contributing to the market growth. In September 2020, Curium launched Detectnet, a positron emission tomography (PET) agent, indicated for the localization of somatostatin receptor-positive neuroendocrine tumors (NETs) in adult patients. Thus, the technological advancements for improving the quality and efficacy of nuclear imaging techniques are favoring the MEA radiopharmaceuticals market growth.
Key Market Segments
In terms of type, the diagnostic nuclear medicine segment accounted for the largest share of the MEA radiopharmaceuticals market in 2020. In terms of application, the oncology segment held a larger market share of the MEA radiopharmaceuticals market in 2020. Further, the hospitals segment held a larger share of the MEA radiopharmaceuticals market based on end user in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the MEA radiopharmaceuticals market are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Advanced Accelerator Applications, Bayer AG, Bracco Imaging S.p.A, Cardinal Health Inc, Curium, ECZACIBA?I MONROL NUCLEAR PRODUCTS CO., GENERAL ELECTRIC, Nordion, and NTP RADIOISOTOPES.
Reasons to buy report
- To understand the MEA radiopharmaceuticals market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for MEA radiopharmaceuticals market
- Efficiently plan M&A and partnership deals in MEA radiopharmaceuticals market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form MEA radiopharmaceuticals market
- Obtain market revenue forecast for market by various segments from 2021-2028 in MEA region.
MEA Radiopharmaceuticals Market Segmentation
MEA Radiopharmaceuticals Market - By Type
- Diagnostic Nuclear Medicine
- SPECT
- PET
- Therapeutic Nuclear Medicine
- Alpha Emitters
- Beta Emitters
- Brachytherapy Isotopes
MEA Radiopharmaceuticals Market - By Application
- Oncology
- Cardiology
- Neurology
- Others
MEA Radiopharmaceuticals Market - By End User
- Hospitals
- Imaging Centers
- Academic and Research Centers
- Others
MEA Radiopharmaceuticals Market - By Country
- Saudi Arabia
- South Africa
- UAE
- Rest of MEA
MEA Radiopharmaceuticals Market - Company Profiles
- Advanced Accelerator Applications
- Bayer AG
- Bracco Imaging S.p.A
- Cardinal Health Inc
- Curium
- ECZACIBA?I MONROL NUCLEAR PRODUCTS CO.
- GENERAL ELECTRIC
- Nordion
- NTP RADIOISOTOPES
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 MEA Radiopharmaceuticals Market – By Type
1.3.2 MEA Radiopharmaceuticals Market – By Application
1.3.3 MEA Radiopharmaceuticals Market – By End User
1.3.4 MEA Radiopharmaceuticals Market– By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. MEA Radiopharmaceuticals Market– Market Landscape
4.1 Overview
4.2 MEA PEST Analysis
4.3 Experts Opinion
5. MEA Radiopharmaceuticals Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Escalation in the Usage of Alpha Radio Immunotherapy
5.1.2 Surging Advancements in Nuclear Imaging Techniques
5.2 Market Restraints
5.2.1 Accessibility of Substitutes
5.3 Market Opportunities
5.3.1 Growth Potential in Several Countries
5.4 Future Trends
5.4.1 Burgeoning Usage of Nuclear Medicines for Personalized Treatment
5.5 Impact Analysis
6. Radiopharmaceuticals Market– MEA Analysis
6.1 MEA Radiopharmaceuticals Market Revenue Forecast and Analysis
7. MEA Radiopharmaceuticals Market Analysis – By Type
7.1 Overview
7.2 MEA Radiopharmaceuticals Market Revenue Share, by Type (2021 and 2028)
7.3 Diagnostic Nuclear Medicine
7.3.1 Overview
7.3.2 Diagnostic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 SPECT
7.3.3.1 Overview
7.3.3.2 SPECT: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 PET
7.3.4.1 Overview
7.3.4.2 PET: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Therapeutic Nuclear Medicine
7.4.1 Overview
7.4.2 Therapeutic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3 Alpha Emitters
7.4.3.1 Overview
7.4.3.2 Alpha Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4 Beta Emitters
7.4.4.1 Overview
7.4.4.2 Beta Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
7.4.5 Brachytherapy Isotopes
7.4.5.1 Overview
7.4.5.2 Brachytherapy Isotopes: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
8. MEA Radiopharmaceuticals Market Analysis – By Application
8.1 Overview
8.2 MEA Radiopharmaceuticals Market Revenue Share, by Application (2021 and 2028)
8.3 Oncology
8.3.1 Overview
8.3.2 Oncology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Cardiology
8.4.1 Overview
8.4.2 Cardiology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Neurology
8.5.1 Overview
8.5.2 Neurology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
9. MEA Radiopharmaceuticals Market Analysis – By End User
9.1 Overview
9.2 MEA Radiopharmaceuticals Market Share, by End User, 2021 and 2028, (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Imaging Centres
9.4.1 Overview
9.4.2 Imaging Centres: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Academic and Research Centers
9.5.1 Overview
9.5.2 Academic and Research Centers: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
10. MEA Radiopharmaceuticals Market – Country Analysis
10.1 MEA: Radiopharmaceuticals Market
10.1.1 Overview
10.1.2 MEA: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)
10.1.2.1 Saudi Arabia: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.1 Saudi Arabia: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.2 Saudi Arabia Radiopharmaceuticals Market, by Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.1.2.1 Saudi Arabia: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)
10.1.2.1.2.2 Saudi Arabia: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)
10.1.2.1.3 Saudi Arabia Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
10.1.2.1.4 Saudi Arabia Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)
10.1.2.2 UAE: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.1 UAE: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.2 UAE Radiopharmaceuticals Market, by Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.2.2.1 UAE: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)
10.1.2.2.2.2 UAE a: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)
10.1.2.2.3 UAE Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
10.1.2.2.4 UAE Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.2.3 South Africa: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.1 South Africa: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.2 South Africa Radiopharmaceuticals Market, by Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.3.2.1 South Africa: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)
10.1.2.3.2.2 South Africa: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)
10.1.2.3.3 South Africa Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
10.1.2.3.4 South Africa Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.2.4 Rest of MEA: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.4.1 Rest of MEA: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.4.2 Rest of MEA Radiopharmaceuticals Market, by Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.4.2.1 Rest of MEA: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)
10.1.2.4.2.2 Rest of MEA: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)
10.1.2.4.3 Rest of MEA Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
10.1.2.4.4 Rest of MEA Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)
11. Impact Of COVID-19 Pandemic on MEA Radiopharmaceuticals Market
11.1 MEA: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Inorganic Growth Strategies
12.2.1 Overview
12.3 Organic Growth Strategies
12.3.1 Overview
13. Company Profiles
13.1 Cardinal Health Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Curium
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 GENERAL ELECTRIC
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Bayer AG
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Bracco Imaging S.p.A
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 ECZACIBAI MONROL NUCLEAR PRODUCTS CO.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Nordion
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 NTP RADIOISOTOPES
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Advanced Accelerator Applications
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. MEA Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)
Table 2. Saudi Arabia Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 3. Saudi Arabia Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 4. Saudi Arabia Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 5. Saudi Arabia Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 6. Saudi Arabia Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 7. UAE Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 8. UAE Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 9. UAE Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 10. UAE Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 11. UAE Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 12. South Africa Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 13. South Africa Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 14. South Africa Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 15. South Africa Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 16. South Africa Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 17. Rest of MEA Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 18. Rest of MEA Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 19. Rest of MEA Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)
Table 20. Rest of MEA Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 21. Rest of MEA Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 22. Recent Inorganic Growth Strategies
Table 23. Recent Organic Growth Strategies
Table 24. Glossary of Terms
LIST OF FIGURES
Figure 1. MEA Radiopharmaceuticals Market Segmentation
Figure 2. MEA Radiopharmaceuticals Market Segmentation, By Country
Figure 3. MEA Radiopharmaceuticals Market Overview
Figure 4. Diagnostic Nuclear Medicine Segment Held the Largest Share of the Market in 2021
Figure 5. Saudi Arabia to Show Significant Growth During Forecast Period
Figure 6. MEA PEST Analysis
Figure 7. MEA Radiopharmaceuticals Market Impact Analysis of Drivers and Restraints
Figure 8. MEA Radiopharmaceuticals Market– Revenue Forecast and Analysis
Figure 9. MEA Radiopharmaceuticals Market Revenue Share, by Type (2021 and 2028)
Figure 10. MEA Diagnostic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. MEA SPECT: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. MEA PET: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. MEA Therapeutic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. MEA Alpha Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. MEA Beta Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. MEA Brachytherapy Isotopes: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. MEA Radiopharmaceuticals Market Revenue Share, by Application (2021 and 2028)
Figure 18. MEA Oncology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. MEA Cardiology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. MEA Neurology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. MEA Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. MEA Radiopharmaceuticals Market Share, by End User, 2021 and 2028 (%)
Figure 23. MEA Hospitals: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. MEA Imaging Centres: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. MEA Academic and Research Centers: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. MEA Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. MEA: Radiopharmaceuticals Market, by Key Country – Revenue (2021) (USD Million)
Figure 28. MEA: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)
Figure 29. Saudi Arabia: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)
Figure 30. UAE: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)
Figure 31. South Africa: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)
Figure 32. Rest of MEA: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (US$ Million)
Figure 33. Impact of COVID-19 Pandemic in MEA Country Markets
- Advanced Accelerator Applications
- Bayer AG
- Bracco Imaging S.p.A
- Cardinal Health Inc
- Curium
- ECZACIBA?I MONROL NUCLEAR PRODUCTS CO.
- GENERAL ELECTRIC
- Nordion
- NTP RADIOISOTOPES
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the MEA radiopharmaceuticals market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the MEA radiopharmaceuticals market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth MEA market trends and outlook coupled with the factors driving the radiopharmaceuticals market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution